---
title: "Pelthos Therapeutics (PTHS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PTHS.US/norm.md"
symbol: "PTHS.US"
name: "Pelthos Therapeutics"
parent: "https://longbridge.com/en/quote/PTHS.US.md"
datetime: "2026-03-10T05:20:18.048Z"
locales:
  - [en](https://longbridge.com/en/quote/PTHS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PTHS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PTHS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/PTHS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PTHS.US/norm.md)


# Pelthos Therapeutics (PTHS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -5.30 | -5.38 | -3.21 | -3.19 | -2.93 |
| ROE | -250.98% | 258.10% | 227.80% | 372.18% | 842.23% |
| Revenue | 7.41M | - | - | - | - |
| Net income | -16.24M | -3.45M | -1.97M | -1.93M | -1.70M |
| Operating income | -15.36M | -3.23M | -1.83M | -1.83M | -2.05M |
| Gross margin | 68.73% | - | - | - | - |
| Net margin | -219.25% | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 126.43M | 822850.00 | 911179.00 | 1.37M | 2.14M |
| Leverage | 2.17 | -0.1267 | -0.2172 | -0.5045 | -1.50 |
| BVPS | 18.85 | -9.65 | -6.79 | -4.45 | -2.45 |
| Turnover | 0.1152 | - | - | - | - |
| Cash & STI | 14.20M | 59172.00 | 131317.00 | 513443.00 | 1.25M |
| Inv & Rec | 24.10M | - | - | - | - |
| LT assets | 13.53M | - | - | - | - |
| Net debt | -10.72M | 2.25M | 2.37M | 1.67M | 1.03M |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -15.26M | -447145.00 | -632126.00 | -670264.00 | -177692.00 |
| Investing CF | 2.76M | - | - | - | - |
| Financing CF | 26.69M | 375000.00 | 250000.00 | -71196.00 | -972015.00 |
| Free CF | -21.32M | 799509.00 | 40001.00 | 36384.00 | -1.45M |
| OCF coverage | -1805.77% | - | - | - | -73124.28% |
| Repaid & issued | 68000.00 | 375000.00 | 250000.00 | -153816.00 | -897284.00 |
| CapEx | - | - | - | - | - |